Search

everythinglearnresearchcommunity

for

Search:↓

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Finasteride causes temporary cell death in BPH tissues.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Herbal treatments can help manage PCOS symptoms.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Microneedling is a promising, simple, and cost-effective treatment for hair loss that works well with other therapies.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

The document is a detailed medical reference on skin and genetic disorders.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

The EMG-to-force model accurately predicts hip muscle forces during walking.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.